Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,816.89
(
-0.11%
)
US TECH 100
24,499.60
(
0.38%
)
Dow Jones
47,916.57
(
-0.56%
)
Brent Oil
92.41
(
0.00%
)
Bitcoin
73,064.02
(
0.12%
)
News Focus
News Focus
Post# of 257382
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

RNsidersbuying

Send PM Follow Ignore
Followers 48
Posts 4766
Boards Moderated 0
Alias Born 07/26/2010

RNsidersbuying

Re: RNsidersbuying post# 234181

Tuesday, 09/15/2020 8:24:01 AM

Tuesday, September 15, 2020 8:24:01 AM

Post# of 257382
ABUS 2.94 - "Arbutus Announces AB-729 90 mg Single-Dose Week 12 Data in Chronic Hepatitis B Subjects Demonstrating Significant and Continuous Reductions in HBsAg"

https://finance.yahoo.com/news/arbutus-announces-ab-729-90-113000767.html

Would love to hear comments on this update? I still believe ABUS is a low-risk investment at under-$4 pps as a stand-alone...excluding...the absolute rocketship potential here if/WHEN it's "069-Patent" makes the 6:00 0'clock news...
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today